Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.
about
RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth.Injectable sustained release microparticles of curcumin: a new concept for cancer chemopreventionHuman ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules.Endothelial cell differentiation of human breast tumour stem/progenitor cells.The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.Critical role of CDK11(p58) in human breast cancer growth and angiogenesisMechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival.Isolation and Culture Expansion of Tumor-specific Endothelial CellsCD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells.Use of immunohistochemistry in the diagnosis of problematic breast lesions.Effects of Chlorella vulgaris on tumor growth in mammary tumor-bearing Balb/c mice: discussing association of an immune-suppressed protumor microenvironment with serum IFNγ and IgG decrease and spleen IgG potentiation.Is Sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?Relationship between morphological and cytogenetic heterogeneity in invasive micropapillary carcinoma of the breast: a report of one case.Paget's disease of the nipple.
P2860
Q24531821-67B21209-9750-40E9-BAE3-6562B71F7DEDQ33645244-C77404EC-196D-4925-ACDF-C7443B3E3E20Q33892008-0FC50F3A-81FC-4A03-A672-28982172AF79Q34025938-5013AECA-A430-492E-8437-78B52D24FB66Q34919522-B32B15B6-42A1-41F2-9635-ED71FE9E5133Q35009446-3DCF5C5F-C9FF-4415-A5A2-54B46ACAD7BEQ35749239-79CF608D-E198-496B-9D63-595B7744BD84Q35809147-53E79D8A-AE82-4C40-9052-3A210F615074Q36272597-1DA40481-66C7-492E-9218-337B061031AFQ36408245-795848EE-4D42-42C9-921B-72DDA07AF4DEQ37674342-0C4EF7B1-E914-4B1F-A4C3-28AA59E1F526Q38088953-C07D6C2E-606D-4D2D-AB1E-8F37111665E2Q38754346-D05F4BE7-1C85-4D5F-BB83-D6460E38397DQ46269313-FB79AC92-E8D0-4A15-A5BF-1FFC9750F57BQ48172709-78D11D26-F089-4F35-AFF2-92B8E91CE393Q53250851-DC47AA59-C289-44AF-A91A-20D5922BCC51
P2860
Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@en
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@nl
type
label
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@en
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@nl
prefLabel
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@en
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@nl
P2093
P2860
P1476
Expression of CD31 by cells of ...... sive carcinomas of the breast.
@en
P2093
P2860
P304
P356
10.1002/1096-9896(200106)194:2<254::AID-PATH880>3.0.CO;2-2
P577
2001-06-01T00:00:00Z